Loading clinical trials...
Loading clinical trials...
To evaluate the feasibility of using a smartphone application for monitoring and evaluation of Raynaud's Phenomenon.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Grenoble
NCT03867097 · Raynaud Phenomenon Secondary to Systemic Sclerosis
NCT04388176 · Raynaud Phenomenon, Systemic Sclerosis
NCT03972566 · CREST Syndrome, Calcinosis Cutis, and more
NCT03094910 · Raynaud Disease, Raynaud Phenomenon, and more
NCT03027674 · Raynaud Phenomenon Due to Trauma, Raynaud Disease, and more
Chu Grenoble Alpes
Grenoble, Grenoble
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions